Related Experiment Video
Updated: Jun 22, 2026

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
Published on: February 15, 2018
Human milk glycans protect infants against enteric pathogens
David S Newburg1, Guillermo M Ruiz-Palacios, Ardythe L Morrow
1Division of Pediatric Gastroenterology and Nutrition, Massachusetts General Hospital, Charlestown, Massachusetts 02129-4404, USA. dnewburg@partners.org
Human milk oligosaccharides (HMOs) protect breastfed infants from pathogens by inhibiting pathogen binding. These protective glycans are a key component of human milk's innate immune system, offering a basis for new disease-preventing agents.
Area of Science:
- Human milk composition
- Immunology
- Glycobiology
Background:
- Breastfed infants exhibit reduced morbidity and mortality compared to artificially fed infants, primarily attributed to milk's immune factors.
- Human milk oligosaccharides (HMOs), once considered non-functional, are now recognized as complex components with protective roles.
- Pathogen inhibition by HMOs is mainly through preventing pathogen attachment to host cells.
Purpose of the Study:
- To review the protective role of human milk oligosaccharides (HMOs) against pathogens.
- To present the argument that specific glycans in human milk constitute an innate immune system.
- To explore the potential of these protective glycans as therapeutic agents.
Main Methods:
- Literature review of studies on human milk oligosaccharides and infant health.
- Analysis of the mechanisms by which HMOs inhibit pathogen binding.
- Examination of the relationship between maternal genetics (Lewis blood group) and HMO composition.
Main Results:
- Human milk oligosaccharides (HMOs) are composed of thousands of components, many protecting against pathogens.
- Fucosylated HMOs, influenced by maternal Lewis blood group type, are key in protecting infants from infectious diseases.
- Specific glycans, particularly HMOs, act as a major innate immune constituent in human milk.
Conclusions:
- Specific glycans, especially HMOs, form a crucial innate immune system in human milk, protecting infants from pathogens.
- The synthesis of HMOs represents a significant maternal energy investment, aligning with reproductive strategies.
- These protective glycans hold promise for developing novel prophylactic and therapeutic agents against mucosal pathogens.
More Related Videos
08:12Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
Published on: September 6, 2019
09:36Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Related Concept Videos
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Glycocalyx and its Functions
Components of...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of Human Microbiota
Development of the Oral Microbiota